A Randomized Study to Compare the Dosing Schedule of INFeD in Anemic Patients.

Status:
Withdrawn

Trial end date:
2018-08-31

Target enrollment:

Participant gender:

The purpose of this study is to establish which dosing schedule of INfed (Iron dextrose) is superior for the treatment of iron deficient anemia.

Phase 4

Sutter Gould Medical Foundation